Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Non-small Cell Lung Cancer: Cause

Description: There has been a rapid increase in the incidence of lung cancer since the 1930s. The association between cigarette smoking and lung cancer was first proposed in 1941, and has been substantiated with epidemiological studies. Thus, as the numbers of cigarette-smoking individuals in a given population rises and falls, so do the rates of lung cancer. Lung cancer can be classified as either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC), based on the characteristics of the disease and its response to treatment. This course presents scientific information and statistics about non-small cell lung cancer and NSCLC classifications.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PATHOPHYSIOLOGY
4. Objectives
5. Lung Anatomy
6. Pathogenesis
7. Tumor Growth and Metastasis
8. Molecular Basis
9. Classification
10. Progress Check

EPIDEMIOLOGY
11. Objectives
12. Epidemiology
13. Risk Factors
14. Progress Check

CONCLUSION
15. Summary


COURSE OBJECTIVES
Students completing this course should be able to:
  • Describe lung anatomy
  • List the different types of lung cancer and the sub-classifications of non-small cell lung cancer
  • Explain possible molecular mechanisms for the development of lung cancer
  • List the incidence of lung cancer worldwide
  • List the mortality statistics of various genders and ethnicities within the United States
  • Describe the risk factors for the development of lung cancer

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy